Skip to content
Hernantala

Hernantala

  • Perfil Profesional
  • Artículo
  • Videos
  • Contáctame
  • Perfil Profesional
  • Artículo
  • Videos
  • Contáctame

pusitkttrnr@gmail.com

Estudio y manejo de nódulos tiroideos por médicos no especialistas.

March 11, 2021March 11, 2021 Article

The thyroid nodule is a frequent cause of primary care consultation. The prevalence of a palpable thyroid nodule is approximately 4-7%, increasing up to 67% by the incidental detection of nodules on ultrasound. The vast majority are benign and asymptomatic, staying stable over time. The clinical importance of studying a thyroid nodule is to exclude […]

pusitkttrnr@gmail.com

March 11, 2021

PROTOCOLO CLÍNICOCÁNCER DIFERENCIADO DE TIROIDESPROGRAMA DE CÁNCER DEL ADULTO 2020

March 11, 2021March 11, 2021 Article

pusitkttrnr@gmail.com

March 11, 2021

PROTOCOLO CLÍNICOCÁNCER MEDULAR DE TIROIDES

May 26, 2020March 11, 2021 Article

En Chile, la incidencia de cáncer de tiroides es de 7,86 casos nuevos por 100.000 habitantes/año, siendo su prevalencia levemente mayor en mujeres que hombres (11.7/100.00en mujeres)

pusitkttrnr@gmail.com

May 26, 2020

A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology

January 26, 2020March 11, 2021 Article

Although most thyroid nodules with indeterminate cytology are benign, in most of the world surgery remains as the most frequent diagnostic management. We have previously reported a 10-gene thyroid genetic classifier which accurately predicts benign thyroid nodules.

pusitkttrnr@gmail.com

January 26, 2020

Prospective validation of the ultrasound based TIRADS (Thyroid Imaging Reporting And Data System) classification: results in surgically resected thyroid nodules

June 26, 2017March 11, 2021 Article

Between June 2009 and October 2012, patients assessed with pre-operative ultrasound (US) were included in this IRB-approved study. Nodules were categorised according to our previously described TIRADS classification.

pusitkttrnr@gmail.com

June 26, 2017

Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry-Based Approach to Radioactive Iodine Treatment

February 26, 2017March 11, 2021 Article

The optimal management of radioactive iodine (RAI) treatment in patients with metastatic thyroid cancer (TC) is still a matter of debate.

pusitkttrnr@gmail.com

February 26, 2017

Skeletal-related events due to bone metastases from differentiated thyroid cancer

June 26, 2012March 11, 2021 Article

In oncology, the clinical impact of metastatic bone disease is conveyed via a composite end point termed skeletal-related events (SRE), which encompasses spinal cord compression, pathological fracture, a need for external beam radiation or surgery to bone, and hypercalcemia of malignancy.

pusitkttrnr@gmail.com

June 26, 2012

The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma

September 26, 2011March 11, 2021 Article

Measurement of serum Tg using ultrasensitive assays is proposed to replace TSH-stimulated Tg measurement in the follow-up of differentiated thyroid cancer (DTC). Aim of our study was to verify this possibility using two ultrasensitive Tg assays.

pusitkttrnr@gmail.com

September 26, 2011

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation

December 26, 2010March 11, 2021 Article

A risk-adapted approach to management of thyroid cancer requires risk estimates that change over time based on response to therapy and the course of the disease. The objective of this study was to validate the American Thyroid Association (ATA)

pusitkttrnr@gmail.com

December 26, 2010

New splicing mutation of MEN1 gene affecting the translocation of menin to the nucleus

November 26, 2006March 11, 2021 Article

Multiple endocrine neoplasia type 1 (MEN1) is a syndrome inherited in an autosomal dominant trait caused by the inactivation of the tumor suppressor gene MEN1.

pusitkttrnr@gmail.com

November 26, 2006

Dr. Hernàn Tala

Endocrinologist

©2021 Doctor Marketing by Philip James. All Rights Reserved.